Latest filing published 20 Oct 2010 for VALEANT PHARMACEUTICALS INTERNATIONAL.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Steve T. Min on record concern Valeant Pharmaceuticals International. Between 30 June 2008 and 28 September 2010, the trades on record add up to 14 filings.
Every open-market trade on record is a purchase: 6 purchases worth €129k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 7 share grants.
A typical purchase (the median) is worth €22k.
On 20 October 2010 came the latest disclosure, a transaction in Valeant Pharmaceuticals International. The clock since the last published purchase (11 August 2008) now reads 6,647 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations